Price: 74.14

Today's Change: -3.74

Today's Percent Change: -2.52%

Today's Volume: 9663399

Average Daily Volume: 9388340

52 week low: 63.76

52 week high: 86.27

Market cap: 96820000000.0

EBITDA: 17970000000.0

EBITDA / market_cap: 18.56%

Earnings per Share (EPS): 9.21

EPS / price: 12.42%

Dividend Yield: 2.6%

Dividend per share: 2.08

Book value: 17.36

Price to Book Ratio: 4.49

Price to Earnings (P/E) Ratio: 8.05

Price to Earnings Growth (PEG) Ratio: -1.08

Price to Sales (P/S) Ratio: 3.57

Short Ratio: 2.17

Exchange: "NMS"

Short term: UP (Previous: UP)

Mid term: UP (Previous: UP)

Long term: UP (Previous: UP)

Support: 65.57

Resistance: 66.73

Pivot point: 66.23

SMA 10: 67.43

SMA 50: 67.49

SMA 100: 69.31

RSI 10: 37.42

RSI 50: 44.29

RSI 100: 44.87

EMA 10: 67.61

EMA 50: 67.64

EMA 100: 69.95

STRONG BUY

Based on 12 buy signals and 0 sell signals

Previous signal: strong buy

73.60

NEGATIVE

GILD
GILD

@AlertTrade: RT @getvolatility: Cheap call option upside: $CMG calls cheaper than 89% of history, $OKTA 89%, $XRT 89%, $TWTR 89%, $GILD 89%, $CLF 89%, $…

@getvolatility: Cheap call option upside: $CMG calls cheaper than 89% of history, $OKTA 89%, $XRT 89%, $TWTR 89%, $GILD 89%, $CLF 89%, $GDX 89%

@bulletin_en: As Gilead Sciences $GILD Valuation Declined, Holder Aimz Investment Advisors Has Lifted Its Position; Deccan Value… https://t.co/oJIdZYV7y0

@TheMarketsDaily: Evercore ISI Reaffirms Buy Rating for Gilead Sciences $GILD https://t.co/Wst2Q1rE3R

@TradeStocksNow1: https://t.co/s6lVxNDe7C < My Review of The Best Stock Alerts + Watch list around $AMZN $NVDA $GILD

@eveharris22: RT @SPGMarketIntel: ICYMI: Gilead's new CEO defends HIV drug Truvada's price and insists Centers for Disease Control and Prevention patents…

@FlyOnTheWallHQ: RT @StockWatchHQ: Gilead Sciences $GILD Confirmation Of Dynavax Technologies $DVAX Acquisition Discussions, Announcement As Early As Tuesda…

@OlympiaReport: Zacks: Brokerages Expect Gilead Sciences, Inc. $GILD Will Announce Quarterly Sales of $5.53 Billion https://t.co/0mLICcXSYP

@FlyOnTheWallHQ: RT @StockWatchHQ: Following Downgrade Sangamo Therapeutics $SGMO Assessing New Acquisition Offer From Gilead Sciences $GILD In Foster City,…

@FlyOnTheWallHQ: RT @StockWatchHQ: GlaxoSmithKline $GSK Close To Finalizing Buyout Of Achillion Pharmaceuticals $ACHN, Announcement As Wednesday https://t.c…

@ExactOptionPick: Don't miss our next FREE OPTION TRADE. Sign up for our Daily Free Trades at https://t.co/YLHjMJk6WL $NVDA $TSLA $GS $GILD $F $GOOGL $FB

@trstueve: RT @ByAmyBrown: Conclusions of Michel Sadelain’s special session on CAR-T at #ESMO18 $GILD $NVS https://t.co/6JQuYWTMnt

@osman2009a: RT @TomSilver39: Cowen Q2:19 BIOTECH SENTIMOMETER SURVEY HIGHLIGHTS A MORE BEARISH VIEW OF SECTOR, Investors picked $MRTX, $SAGE, and $SRPT…

@FlyOnTheWallHQ: RT @StockWatchHQ: Gilead Sciences $GILD CEO To Confirm Amgen $AMGN Acquisition Discussions Happening In Foster City https://t.co/PNKET4QvUU…

@shortvolumes: Short sale volume(not short interest) for $ADMA on 2019-05-17 is 36%. https://t.co/d9Xs6nYZlj $GILD 42% $CAG 67% $CSX 42% $LOW 63%